Danny Eckert

Dr. Danny J. Eckert, a leading sleep and respiratory physiologist and director at the Adelaide Institute for Sleep Health, discusses his groundbreaking work on OSA endotyping. He reveals that 70% of OSA patients suffer from non-anatomical causes, stressing the need for tailored treatment approaches. The chat covers innovative methodologies for assessing airway collapse and explores the significant impact of nasal obstruction on sleep quality. Eckert also highlights the potential of non-PAP treatments and new biomarkers for an improved understanding and management of obstructive sleep apnea.